IBN Announces ‘Test. Optimize. Scale.’ Interview with BiondVax Pharmaceuticals Ltd. CEO Amir Reichman Discussing De-Risked Development Pipeline and Strategic Partnerships with Premier European Research Institutes
03 mars 2023 14h07 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, March 03, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN, a multifaceted financial news and publishing company for private and public entities, today announces that Amir Reichman, CEO...
Biotech Q&A; BioSante Announces Completion of Enrollment in LibiGel Safety Study With a Minimum 90 Percent Predictive Probability of Success of the Safety Study
08 juin 2011 09h41 HE
|
InvestorIdeas.com
POINT ROBERTS, WA and LINCOLNSHIRE, IL--(Marketwire - Jun 8, 2011) - Investorideas.com, an investor research portal covering leading sectors including biotech and pharma stocks, features an exclusive...
Q&A Interview With Pharmaceutical Company, BioSante Pharmaceuticals (NASDAQ: BPAX)
05 nov. 2010 09h00 HE
|
Investorideas.com; BioSante Pharmaceuticals
POINT ROBERTS, WA--(Marketwire - November 5, 2010) - www.investorideas.com, an investor research portal covering leading sectors including biotech and pharma stocks, presents a Q&A interview with...